Tag: CBT > Cannabis Rescheduling: Page 11

Cannabis Rescheduling

US Health and Human Services Department Recommends Cannabis Reclassified to Schedule III

The move from Schedule I to Schedule III would provide that cannabis has a federally accepted medical use, but the decision now goes to the DEA.

August 30, 2023

Cannabis Rescheduling

New Coalition Launches Campaign in Support of Cannabis Scheduling Reform

As the Biden Administration actively reviews the classification of cannabis under the Controlled Substances Act, a diverse group of cannabis companies and organizations is partnering with scientific and legal experts to launch the Coalition for Cannabis Scheduling Reform.

June 6, 2023

Adult-Use Legalization Bill

After Oklahoma, the Cannabis Industry Eagerly Awaits Legalization Action Elsewhere

Attorneys share their reactions to state legislatures considering legalization, what they make of voters rejecting an adult-use market in Oklahoma, and what it all means for federal policy reform.

March 14, 2023

The Last Word

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

March 13, 2023

Cannabis Rescheduling

US Representative Reintroduces Legislation to Reschedule Cannabis

Rep. Greg Steube has reintroduced the Marijuana 1-to-3 Act, which would reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.

February 1, 2023

Hemp Research

Risky Research

January 5, 2023

Cannabis Rescheduling

Helpful, or Yet Another Hurdle?

Many industry experts agree President Joe Biden’s three-step cannabis reform plan was historic and removing the plant from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster'—for state-legal markets.

December 23, 2022

Interviews & Opinion

What’s Next for the Cannabis Industry Following the Midterm Elections?

Cannabis-focused attorneys share their predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift heading into next year.

November 18, 2022

Legislation and Regulation

Texas Congressman Compares ‘In It To Make Money’ Cannabis Industry to Slavery; Alabama Mayor Takes Issue

Rep. Pete Sessions’ comment came during a House subcommittee hearing on federal cannabis reform; Mayor Randall Woodfin called it offensive.

November 16, 2022

Legislation and Regulation

Witnesses Stress Need For Cannabis Descheduling, Uniform Regulation at US House Hearing on Federal Reform

Cannabis advocates say that through federal reform, the U.S. government can work to ensure a thriving industry, social equity and justice in communities of color, treatment for veterans with PTSD and more while reducing the illicit market.

November 15, 2022

Legislation and Regulation

Global Alliance for Cannabis Commerce Discusses Federal and State Cannabis Policy Ahead of Congressional Hearing Testimony

GACC leaders Randal John Meyer and Rezwan Khan broke down some of the industry trade group’s approaches and positions on state and federal reform.

November 14, 2022

Legislation and Regulation

To Reschedule or Deschedule? Plant-Touching Businesses Weigh In

Owners and operators of cannabis companies across the U.S. say they would like to see cannabis completely descheduled as a result of President Joe Biden’s order to review cannabis’s status under the Controlled Substances Act.

November 7, 2022